Literature DB >> 29443199

Managing loss of intrathecal baclofen efficacy: Review of the literature and proposed troubleshooting algorithm.

Aaron Boster1, Jacqueline Nicholas1, Mary Pat Bartoszek1, Colleen O'Connell1, Chima Oluigbo1.   

Abstract

Spasticity is a debilitating symptom associated with numerous neurologic conditions. While intrathecal baclofen therapy (ITB) is an established treatment for spasticity, complications can lead to loss of efficacy (LOE) and baclofen withdrawal. Untreated withdrawal syndrome can be fatal. Prompt diagnosis and management of LOE is essential. Numerous methods have been described in the literature for diagnosing the cause of LOE. Many of the methods require equipment not readily available in the outpatient setting. Furthermore, there is no established consensus on the sequencing of these diagnostic tests. Herein, we review ITB literature on troubleshooting LOE for applicability to the managing clinician. Using this information and our clinical experience, we propose an algorithm with management recommendations to simplify and expedite the troubleshooting process in the outpatient setting.

Entities:  

Year:  2014        PMID: 29443199      PMCID: PMC5765615          DOI: 10.1212/cpj.0000000000000000

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN: 2163-0402


  16 in total

1.  Assessing syndromes of catheter malfunction with SynchroMed infusion systems: the value of spiral computed tomography with contrast injection.

Authors:  Michael S Turner
Journal:  PM R       Date:  2010-08       Impact factor: 2.298

2.  Scintigraphic evaluation of intrathecal infusion systems: selection of patients for surgical or medical management.

Authors:  J F Stinchon; N P Shah; J Ordia; E Oates
Journal:  Clin Nucl Med       Date:  2006-01       Impact factor: 7.794

Review 3.  Intrathecal baclofen therapy: an update.

Authors:  Gerard E Francisco; Michael F Saulino; Stuart A Yablon; Michael Turner
Journal:  PM R       Date:  2009-09       Impact factor: 2.298

4.  Tolerance to continuous intrathecal baclofen infusion can be reversed by pulsatile bolus infusion.

Authors:  H W Heetla; M J Staal; T van Laar
Journal:  Spinal Cord       Date:  2009-11-17       Impact factor: 2.772

5.  Incidence and identification of intrathecal baclofen catheter malfunction.

Authors:  Eric M Dvorak; John R McGuire; Mary Elizabeth S Nelson
Journal:  PM R       Date:  2010-07-03       Impact factor: 2.298

6.  Exacerbation by dextroamphetamine of spasticity in a patient with motor neuron disease.

Authors:  J R Rundell; E H Cassem; G B Murray
Journal:  J Clin Psychopharmacol       Date:  1988-04       Impact factor: 3.153

7.  Theophylline exacerbating spasticity.

Authors:  J E Clark; J K Devenport
Journal:  JAMA       Date:  1983 Jul 22-29       Impact factor: 56.272

8.  Comparison of glatiramer acetate (Copaxone) and interferon beta-1b (Betaferon) in multiple sclerosis patients: an open-label 2-year follow-up.

Authors:  S Flechter; J Vardi; L Pollak; J M Rabey
Journal:  J Neurol Sci       Date:  2002-05-15       Impact factor: 3.181

Review 9.  Acute intrathecal baclofen withdrawal: a brief review of treatment options.

Authors:  James C Ross; Aaron M Cook; Gary L Stewart; Brenda G Fahy
Journal:  Neurocrit Care       Date:  2011-02       Impact factor: 3.210

10.  Intrathecal baclofen for stiff-person syndrome: life-threatening intermittent catheter leakage.

Authors:  J Bardutzky; V Tronnier; S Schwab; H-M Meinck
Journal:  Neurology       Date:  2003-06-24       Impact factor: 9.910

View more
  1 in total

1.  Managing loss of intrathecal baclofen efficacy: Review of the literature and proposed troubleshooting algorithm.

Authors:  Joe Ordia; Julien Vaisman
Journal:  Neurol Clin Pract       Date:  2014-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.